Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by George Y. Gillespie
287. Improved Outcomes Following Drug-Resistant Immunotherapy in a Human Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
A Phase 1 Trial of ABT-510 Concurrent With Standard Chemoradiation for Patients With Newly Diagnosed Glioblastoma
Archives of Neurology
Related publications
Metabolic Targeting of EGFRvIII/PDK1 Axis in Temozolomide Resistant Glioblastoma
Oncotarget
Oncology
T-Cell Apoptosis in Human Glioblastoma Multiforme: Implications for Immunotherapy
Journal of Neuroimmunology
Allergy
Immunology
Neurology
Using Temozolomide in Newly Diagnosed Glioblastoma Multiforme – A Single-Centre Experience
Wspolczesna Onkologia
Oncology
Radiology
Nuclear Medicine
Imaging
Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme
Frontiers in Oncology
Cancer Research
Oncology
Local Delivery of Cannabinoid-Loaded Microparticles Inhibits Tumor Growth in a Murine Xenograft Model of Glioblastoma Multiforme
PLoS ONE
Multidisciplinary
Metformin and Temozolomide, a Synergic Option to Overcome Resistance in Glioblastoma Multiforme Models
Oncotarget
Oncology
Pseudoprogression Following Chemoradiotherapy for Glioblastoma Multiforme
Canadian Journal of Neurological Sciences
Medicine
Neurology
A Tumor-Targeting P53 Nanodelivery System Limits Chemoresistance to Temozolomide Prolonging Survival in a Mouse Model of Glioblastoma Multiforme
Nanomedicine: Nanotechnology, Biology, and Medicine
Materials Science
Molecular Medicine
Nanoscience
Pharmaceutical Science
Medicine
Bioengineering
Nanotechnology
Biomedical Engineering
Crosslink Between Temozolomide and PD-L1 Immune-Checkpoint Inhibition in Glioblastoma Multiforme
BMC Cancer
Cancer Research
Oncology
Genetics